Viropro Stock Forecast - Simple Regression
Viropro Stock outlook is based on your current time horizon.
As of today the value of rsi of Viropro's share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Viropro hype-based prediction, you can estimate the value of Viropro from the perspective of Viropro response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Viropro on the next trading day is expected to be 0.00 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Viropro after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Viropro to cross-verify your projections. To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.Viropro Additional Predictive Modules
Most predictive techniques to examine Viropro price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Viropro using various technical indicators. When you analyze Viropro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Viropro Simple Regression Price Forecast For the 26th of January
Given 90 days horizon, the Simple Regression forecasted value of Viropro on the next trading day is expected to be 0.00 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict Viropro Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Viropro's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Viropro Stock Forecast Pattern
| Backtest Viropro | Viropro Price Prediction | Buy or Sell Advice |
Viropro Forecasted Value
In the context of forecasting Viropro's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Viropro's downside and upside margins for the forecasting period are 0.00 and 0.00, respectively. We have considered Viropro's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Viropro stock data series using in forecasting. Note that when a statistical model is used to represent Viropro stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Viropro
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Viropro. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Viropro Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Viropro is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Viropro backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Viropro, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.00 | 0.00 | 0.00 |
|
Viropro Hype Timeline
Viropro is at this time traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Viropro is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Viropro is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has Price to Book (P/B) ratio of 1.17. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viropro had not issued any dividends in recent years. The entity had 1:12.14 split on the 26th of November 2003. Given the investment horizon of 90 days the next projected press release will be any time. Check out Historical Fundamental Analysis of Viropro to cross-verify your projections. To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.Viropro Related Hype Analysis
Having access to credible news sources related to Viropro's direct competition is more important than ever and may enhance your ability to predict Viropro's future price movements. Getting to know how Viropro's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Viropro may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| YECO | Yulong Eco Materials | 0.00 | 0 per month | 0.00 | (0.0008) | 0.00 | 0.00 | 42.46 | |
| SQZB | SQZ Biotechnologies | 0.00 | 0 per month | 0.00 | 0.02 | 3.45 | (3.33) | 50.43 | |
| SYBE | SYBLEU INC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EMMA | Emmaus Life Sciences | 0.00 | 0 per month | 6.15 | 0.09 | 20.37 | (13.43) | 64.24 | |
| BITRF | Biotron Limited | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | (18.75) | 1,073 | |
| TSOI | Therapeutic Solutions International | 0.00 | 0 per month | 0.00 | 0.16 | 0.00 | 0.00 | 1,100 | |
| MCET | Multicell Techs | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 1,100 | |
| JRSS | JRSIS Health Care | 0.00 | 0 per month | 10.41 | 0.14 | 48.95 | (25.71) | 214.12 | |
| CAFS | Caf Serendipity Holdings | 0.00 | 0 per month | 0.00 | (0.05) | 5.71 | 0.00 | 86.07 | |
| PRCNF | Pure Global Cannabis | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Viropro
For every potential investor in Viropro, whether a beginner or expert, Viropro's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Viropro Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Viropro. Basic forecasting techniques help filter out the noise by identifying Viropro's price trends.Viropro Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Viropro stock to make a market-neutral strategy. Peer analysis of Viropro could also be used in its relative valuation, which is a method of valuing Viropro by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Story Coverage note for Viropro
The number of cover stories for Viropro depends on current market conditions and Viropro's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Viropro is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Viropro's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Historical Fundamental Analysis of Viropro to cross-verify your projections. To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viropro. If investors know Viropro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viropro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Viropro is measured differently than its book value, which is the value of Viropro that is recorded on the company's balance sheet. Investors also form their own opinion of Viropro's value that differs from its market value or its book value, called intrinsic value, which is Viropro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viropro's market value can be influenced by many factors that don't directly affect Viropro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viropro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viropro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viropro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.